Clinical Trials: An Evaluation of the Efficacy and Safety of AL-46383A Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis

This clinical trial will determine if AL-46383A ophthalmic solution is an effective treatment for adenoviral conjunctivitis.

Study Type: Interventional

Age/Gender Requirements: 6 years+ (male/female)

Sponsor: Alcon Research

Purpose: To determine the safety and efficacy of AL-46383A Ophthalmic Solution in the treatment of adenoviral conjunctivitis.

Click here to access this third-party resource.

Related Videos
Brian LaMoreaux, MD | Credit: Horizon Therapeutics
Natalie McCormick, PhD | Credit: American College of Rheumatology
Related Content
© 2023 MJH Life Sciences

All rights reserved.